Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33395fbb3c84470cf1e34806abcc9928 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53a91a6df2b5f6cb6d3509a62aca7358 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a3721ca264753e2b424149847dc94df http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857845e0fa47ec561d39ccb4832fd8bb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K2003-2213 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-911 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2012-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9df879471f70a91ce5884cbcb25cb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6edfecb511426cf1f87146c6cc0b3e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddf5041eea2f8498d8a31bc107b5ae85 |
publicationDate |
2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9585840-B1 |
titleOfInvention |
Redox active cerium oxide nanoparticles and associated methods |
abstract |
Nanoparticles disclosed in the invention comprise a dextran-coated crystalline structure of cerium oxide wherein tetravalent Ce 4+ predominates over trivalent Ce 3+ and wherein said nanoparticles have a diameter of approximately from 3 to 5 nm. The nanoparticles exhibit both superoxide dismutase activity and catalase activity in an environment having a substantially neutral or acidic pH. The nanoparticles may be used to make and may be contained in a medication. The subject nanoparticles are useful in a method of promoting a cytotoxic anti-invasive effect on squamous tumor cells and inhibit tumor invasiveness. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389536-B2 |
priorityDate |
2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |